630 Fifth Avenue
Suite 2260
New York, NY 10020
United States
650 812 8700
https://www.affymax.com
Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 2
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Mr. Mark G. Thompson | CFO & Secretary | 97.49k | N/A | 1962 |
Mr. Jonathan M. Couchman | CEO, President & Director | N/A | N/A | 1970 |
Dr. Tracy J. Dunn Ph.D., J.D. | Vice President of Intellectual Property & Legal Affairs | N/A | N/A | 1963 |
Affymax, Inc. does not have significant operations. Previously, it was developing drugs to enhance the treatment of serious and often life-threatening conditions in the United States. The company was founded in 2001 and is based in New York, New York.
Affymax, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.